Engineering principles and biological insights can open up new capabilities for biotechnology. This talk will highlight two solutions to challenges faced in improving patient care. First, applying basic principles in chemical engineering to the limitations in blood-based cancer diagnostics today led to new approaches to enhance the amounts of cell-free DNA recovered using a novel 'enhancing agent' similar to contrast agents used in other diagnostics. Second, leveraging biological insights to recast the engineering operations required to enable small biomanufacturing systems for distributed and lower capital-intensive production.
In a year marked by rapid technological change, global market shifts, and urgent climate challenges, MIT serves as a hub for collaborative thinking and meaningful dialogue across sectors. This November, join leading experts at MIT’s flagship event to explore breakthroughs in AI, energy, life sciences, supply chains, space, and more through keynotes, technical sessions, startup showcases, and dynamic discussions.
Contact
Assistant